Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
Journal of the American Geriatrics Society|September 13, 2024
Association of left atrial function with frailty: The Atherosclerosis Risk in Communities (ARIC) studyDaokun Sun, Romil R Parikh, Wendy Wang, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 31, 2023
Association of diabetes and glycemic control with left atrial function: The Atherosclerosis Risk in Communities (ARIC) studyParveen K Garg, Yuekai Ji, Wendy Wang, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|May 13, 2024
Association of Cumulative Systolic Blood Pressure With Left Atrial Function in the Setting of Normal Left Atrial Size: The Atherosclerosis Risk in Communities (ARIC) StudyJeremy R Van't Hof, Romil Parikh, Ethan D Moser, et al.
Journal of the American Heart Association|October 29, 2021
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC StudyWendy Wang, Faye L Norby, Michael J Zhang, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 17, 2025
Greater Central Adiposity Is Associated With Poorer Left Atrial Function: The Atherosclerosis Risk in Communities (ARIC) StudyJorge L Reyes, Joseph J Decker, Romil Parikh, et al.
Frontiers in Cardiovascular Medicine|June 8, 2023
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trialsDaniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, et al.
ESC Heart Failure|February 19, 2026
Clinical and echocardiographic changes after intermittent levosimendan infusion in patients with advanced heart failureMauro Riccardi, Emilia D'Elia, Fabio Fazzari, et al.
Pageof 10